Suggestions
Pascale Tronche
General Manager at Alhena Consult - Regulatory Affairs & Drug Development
Professional Background
Pascale Tronche is an accomplished professional with extensive experience in the pharmaceutical and regulatory affairs sectors. She currently serves as the General Manager at Alhena Consult, where she plays a crucial role in guiding clients through the complexities of regulatory affairs and drug development processes. Her leadership and strategic insights have made significant contributions to ensuring compliance and fostering successful product launches in the highly competitive pharmaceutical landscape.
Before joining Alhena Consult, Pascale held various prominent positions within organizations that emphasize innovation and operational excellence. As a Project Director at Pharma Blue (Blue Reg Group), she was responsible for overseeing multiple projects and ensuring that deliverables met both scientific and regulatory standards. Her strategic vision and ability to manage complex project elements distinguished her as a key leader in the value-driven delivery of healthcare solutions.
Pascale has also been instrumental in global research and development initiatives in her roles at Nicox, where she served as the Director of Global R&D Projects, Planning & Due Diligence, and previously as both a Senior Project Manager and Project Manager. Throughout these roles, her expertise in project management and her deep understanding of drug development processes helped streamline operations and optimize results.
Her tenure at Nicox follows a successful period at Galderma, where she advanced from CMC Project Manager to Licensing Project Manager, developing a comprehensive skill set that blends regulatory knowledge with project management acumen. Furthermore, her early career included significant experience as a Project Manager at Pentech Pharmaceuticals, Inc., setting the foundation for her impressive trajectory in the pharmaceutical industry.
Education and Achievements
Pascale Tronche completed her Ph.D. in Chemistry at Wayne State University, laying a solid academic foundation that has propelled her career in the biopharmaceutical sector. Her studies have equipped her with the analytical skills and scientific knowledge essential for navigating the intricate realms of chemistry and drug development. Additionally, her early education at CPE Lyon has contributed to her robust understanding of chemical engineering and its applications in practical settings.
Over the years, Pascale's dedication to her field has resulted in remarkable advancements in her career, allowing her to manage multifaceted projects that drive innovation within the pharmaceutical industry. As a result of her contributions, she has built a reputation for excellence in project leadership and regulatory strategies.
Her work has not only had an impact on her organizations but has also influenced industry standards, making her a respected figure among peers in the fields of drug development and regulatory compliance.
Achievements
Throughout her career, Pascale Tronche has secured numerous achievements that underscore her expertise and commitment to the pharmaceutical industry. Her leadership roles across multiple organizations have illustrated her capacity to manage complex projects and successfully navigate regulatory frameworks. Under her guidance, teams have effectively advanced research initiatives, leading to the successful launch of innovative therapies that enhance patient outcomes.
Pascale's dedication to continuous learning and professional development has made her adept in various facets of drug development, particularly in regulatory affairs, project planning, and research and development strategies. Furthermore, her ability to collaborate with cross-functional teams has fostered a collaborative environment conducive to innovation and efficiency.
With a career characterized by leadership, strategic planning, and cross-departmental collaboration, it’s evident that Pascale Tronche is a dynamic force in the fields of regulatory affairs and drug development.
